Determinants of Patient-Rated and Clinician-Rated Illness Severity in Schizophrenia

被引:19
作者
Fervaha, Gagan [1 ,2 ]
Takeuchi, Hiroyoshi [1 ,3 ]
Agid, Ofer [1 ,2 ,3 ]
Lee, Jimmy [1 ,3 ]
Foussias, George [1 ,2 ,3 ]
Remington, Gary [1 ,2 ,3 ]
机构
[1] Ctr Addict & Mental Hlth, Schizophrenia Div, Toronto, ON M5T 1R8, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[3] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
关键词
EFFECTIVENESS CATIE PROJECT; NEGATIVE SYNDROME SCALE; ANTIPSYCHOTIC TRIALS; GLOBAL IMPRESSION; RATING-SCALE; LIFE SATISFACTION; SYMPTOM SEVERITY; FOLLOW-UP; PANSS; DEPRESSION;
D O I
10.4088/JCP.14m09128
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: The contribution of specific symptoms on ratings of global illness severity in patients with schizophrenia is not well understood. The present study examined the clinical determinants of clinician and patient ratings of overall illness severity. Method: This study included 1,010 patients with a DSM-IV diagnosis of schizophrenia who participated in the baseline visit of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study conducted between January 2001 and December 2004 and who had available symptom severity, side effect burden, cognition, and community functioning data. Both clinicians and patients completed the 7-point Clinical Global Impressions-Severity of Illness scale (CGI-S), the primary measure of interest in the present study. Symptoms were rated using the Positive and Negative Syndrome Scale and the Calgary Depression Scale for Schizophrenia, and functional status with the Quality of Life Scale. Neurocognition, insight, and medication-related side effects were also evaluated. Results: Clinicians rated illness severity significantly higher than patients (P < .001). There was moderate overlap between CGI-S ratings made by clinicians and patients, with almost one third of patients showing substantial (ie, greater than 1 point) discrepancies with clinician ratings. Clinician-rated CGI-S scores were most strongly associated with positive symptoms, with additional independent contributions made by negative, disorganized, and depressive symptoms, as well as functional outcome (all P values < .01). Patient-rated CGI-S scores, on the other hand, were most closely related to depressive symptoms, with additional independent contributions made by positive and anxiety symptoms, clinical insight, and neurocognition (all P values < .01). Depressive symptoms were the strongest predictor of patient-rated CGI-S scores even in patients with good clinical insight (P < .001). Conclusions: Patient and clinician views of overall illness severity are not necessarily interchangeable and differ in their clinical correlates. Taking these differences into account may enhance patient engagement in care and improve outcomes.
引用
收藏
页码:924 / 930
页数:7
相关论文
共 52 条
[1]   A DEPRESSION RATING-SCALE FOR SCHIZOPHRENICS [J].
ADDINGTON, D ;
ADDINGTON, J ;
SCHISSEL, B .
SCHIZOPHRENIA RESEARCH, 1990, 3 (04) :247-251
[2]   Happiness in first-episode schizophrenia [J].
Agid, Ofer ;
McDonald, Krysta ;
Siu, Cynthia ;
Tsoutsoulas, Christopher ;
Wass, Caroline ;
Zipursky, Robert B. ;
Foussias, George ;
Remington, Gary .
SCHIZOPHRENIA RESEARCH, 2012, 141 (01) :98-103
[3]  
Appelbaum P., 2001, MACARTHUR COMPETENCE
[4]   A RATING-SCALE FOR DRUG-INDUCED AKATHISIA [J].
BARNES, TRE .
BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 :672-676
[5]   CLINICAL GLOBAL IMPRESSIONS (ECDEU) - SOME CRITICAL COMMENTS [J].
BENEKE, M ;
RASMUS, W .
PHARMACOPSYCHIATRY, 1992, 25 (04) :171-176
[6]  
Busner Joan, 2007, Psychiatry (Edgmont), V4, P28
[7]   The Clinical Global Impressions scale: errors in understanding and use [J].
Busner, Joan ;
Targum, Steven D. ;
Miller, David S. .
COMPREHENSIVE PSYCHIATRY, 2009, 50 (03) :257-262
[8]   Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment [J].
Clark, Shaunna L. ;
Souza, Renan P. ;
Adkins, Daniel E. ;
Aberg, Karolina ;
Bukszar, Jozsef ;
McClay, Joseph L. ;
Sullivan, Patrick F. ;
van den Oord, Edwin J. C. G. .
PHARMACOGENETICS AND GENOMICS, 2013, 23 (02) :69-77
[9]  
Cohen J., 2013, Statistical power analysis for the behavioral sciences
[10]   Depression in schizophrenia: A comparison of three measures [J].
Collins, AA ;
Remington, G ;
Coulter, K ;
Birkett, K .
SCHIZOPHRENIA RESEARCH, 1996, 20 (1-2) :205-209